NPPES file of Aug 9, 2026

Mark Caspi, PHARMD

Pharmacotherapy Pharmacist · Phoenix, AZ

Mark Caspi, PHARMD is a pharmacotherapy pharmacist with a practice address in Phoenix, Arizona, and NPI 1508947425, issued on Oct 18, 2006. Check the license with the Arizona board that licenses this profession; the federal record below is the public data PlainDoctor holds for this provider.

Record from CMS NPPES, file of Aug 9, 2026 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1508947425
Name
Mark Caspi
Credential
PHARMD
Primary taxonomy
Pharmacotherapy Pharmacist 1835P1200X
License number
PS 18704 FL
Self-reported in NPPES; status is on the state search
Practice location
4212 N 16TH St, Phoenix, AZ 85016
Phone
(602) 263-1511
Enumerated
Oct 18, 2006
Record last updated
Jul 8, 2007 (not updated in 19 years: call before relying on the address or phone)
Fax
(602) 263-1619
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 4212 N 16TH St

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Andrea Aarseth, RNCritical Care Medicine Registered Nurse1235297292
  2. Deirdre Abellada, RN, PHNRegistered Nurse1710259395
  3. Joby Abraham, RNRegistered Nurse1376814046
  4. Frederick Abramek, MS, PHARMACISTPharmacist1528278736
  5. Karen AcostaRegistered Nurse1659748671
  6. Danton AdairRegistered Nurse1114387917

Verify Mark Caspi in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersWhich Arizona board licenses this professionCheck the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Find the Arizona license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

Pharmacotherapy Pharmacist providers in Arizona

There are 183 pharmacotherapy pharmacist records in Arizona. No Medicare prescribing, quality score, industry payment or hospital affiliation is published for this NPI.

Other pharmacotherapy pharmacist records in Arizona

  1. Kafilat Adeleke, PHARMDChinle, AZ1659035012
  2. Joshua Allman, PHARMDParker, AZ1942028048
  3. Ashley Anderson, PHARMDSacaton, AZ1821206855
  4. Sara Anderson, PHARM.D.Phoenix, AZ1801999735
  5. Eric Anger, PHARMDMesa, AZ1588995658
  6. Kofi AnsahTucson, AZ1053496281
  7. Douglas Baer, RPHFlagstaff, AZ1710159041
  8. Christine Barreuther, RPHTucson, AZ1952366429
  9. Kellie Beiber, PHARM.D.Mesa, AZ1619167574
  10. Stephanie Belbis, PHARM.D.Tucson, AZ1225767460

Common questions

What is Mark Caspi, PHARMD's NPI number?

Mark Caspi, PHARMD's National Provider Identifier (NPI) is 1508947425, issued on Oct 18, 2006. An NPI identifies a provider in billing; it is not a license.

Where is Mark Caspi, PHARMD located?

The NPPES record lists a practice address at 4212 N 16TH St, Phoenix, AZ, 85016. Phone: (602) 263-1511. Providers update this record themselves, so call before visiting.

How can I verify Mark Caspi, PHARMD's license?

Search the Arizona board that licenses this profession; the NPPES record confirms identity only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.